# Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients

> **NCT00911651** · PHASE4 · COMPLETED · sponsor: **University Hospital, Antwerp** · enrollment: 6 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Salbutamol
- **DRUG:** ipratropium bromide

## Key facts

- **NCT ID:** NCT00911651
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2008-07
- **Final completion:** 2008-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2009-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911651, "Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00911651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*